Neurophysiology of opioid poorly responsive pain

Area of Science:

• Pain research
• Neuroscience
• Pharmacology

Background:

• Opioid analgesics are crucial for pain management.
• Understanding mechanisms of opioid-poorly responsive pain is essential for improving treatment efficacy.
• Several factors, including receptor changes and endogenous peptides, may contribute to reduced opioid effectiveness.

Purpose of the Study:

• To review and analyze the potential causes of opioid-poorly responsive pain.
• To evaluate the roles of specific molecular and cellular mechanisms in opioid resistance.
• To identify potential therapeutic targets for enhancing opioid efficacy in resistant pain states.

Main Methods:

• Literature review of studies investigating opioid responsiveness.
• Analysis of evidence for five proposed mechanisms: opioid receptor loss, morphine-3-glucuronide accumulation, changes in F8Fa/CCK peptides, dynorphin actions, and NMDA receptor activation.
• Assessment of the clinical relevance and supporting evidence for each proposed cause.

Main Results:

• Peripheral nerve damage may lead to opioid receptor loss, potentially overcome by increased opioid dosage.
• Accumulation of morphine-3-glucuronide and actions of dynorphin are unlikely major contributors.
• Endogenous peptides cholecystokinin (CCK) and F8Fa may play a role in opioid resistance.
• Spinally generated hypersensitive states via N-methyl-D-aspartate (NMDA) receptor activation are strongly associated with hyperalgesia, allodynia, and reduced opioid sensitivity.

Conclusions:

• Opioid-poorly responsive pain can arise from multiple mechanisms, with NMDA receptor activation and endogenous peptides being significant factors.
• Targeting NMDA receptor-mediated events with drugs like dextrorphan and ketamine presents a promising therapeutic strategy.
• Further research is warranted to elucidate the precise roles of CCK, F8Fa, and NMDA receptors in opioid resistance and to develop effective treatments.